Literature DB >> 14732773

Alcohol dehydrogenase 3 genotype as a risk factor for upper aerodigestive tract cancers.

Inês Nobuko Nishimoto1, Nidia A Pinheiro, Silvia R Rogatto, André Lopes Carvalho, Ricardo Pereira de Moura, Otavia L Caballero, Andrew Simpson, Luiz Paulo Kowalski.   

Abstract

OBJECTIVE: To assess alcohol dehydrogenase 3 (ADH3) polymorphism at position Ile349Val as indicator of risk factor for upper aerodigestive tract (UADT) cancer to verify its association with UADT cancer in nonalcoholic or nonsmoking individuals.
DESIGN: Cross-sectional study.
SETTING: Primary care or referral center. PATIENTS: The study group consisted of 141 consecutive patients with newly diagnosed squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx admitted for surgical treatment. The comparison group consisted of 94 inpatients without cancer from the A. C. Camargo or other São Paulo (Brazil) hospital and 40 healthy individuals. INTERVENTION: All participants were interviewed and data were collected using a structured questionnaire. After written informed consent was obtained, 20 mL of blood was collected in heparinized tubes. MAIN OUTCOME MEASURES: Odds ratio for ADH3 genotypes using logistic regression models.
RESULTS: After adjustment for sex, age, tobacco use, and history of cancer in first-degree family relatives, a significantly higher odds ratio for UADT cancer was observed among individuals with AA genotype and low cumulative alcohol consumption (< or =100 kg of ethanol) (odds ratio = 3.8 [95% confidence interval, 1.5-9.7]). A 4-fold increase in odds ratio for UADT cancer among individuals with AA genotype and low tobacco consumption (< or =25 pack-years) was also found in the adjusted model.
CONCLUSIONS: These results suggest that genotype AA may be a risk factor for UADT cancer, especially in individuals with low alcohol or tobacco consumption. However, further epidemiological case-control or cohort studies, preferably prospective, are needed to establish the exact role of ADH3 polymorphism and its association with the development of UADT cancers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14732773     DOI: 10.1001/archotol.130.1.78

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  3 in total

Review 1.  Genotype, phenotype and cancer: role of low penetrance genes and environment in tumour susceptibility.

Authors:  Ashwin Kotnis; Rajiv Sarin; Rita Mulherkar
Journal:  J Biosci       Date:  2005-02       Impact factor: 2.795

2.  ADH1C Ile350Val polymorphism and cancer risk: evidence from 35 case-control studies.

Authors:  Yao Xue; Meilin Wang; Dongyan Zhong; Na Tong; Haiyan Chu; Xiaojing Sheng; Zhengdong Zhang
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

Review 3.  A review of genetic epidemiology of head and neck cancer related to polymorphisms in metabolic genes, cell cycle control and alcohol metabolism.

Authors:  G Cadoni; S Boccia; L Petrelli; P Di Giannantonio; D Arzani; A Giorgio; E De Feo; M Pandolfini; P Gallì; G Paludetti; G Ricciardi
Journal:  Acta Otorhinolaryngol Ital       Date:  2012-02       Impact factor: 2.124

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.